Search

Displaying results 7211 - 7220 of 7452 in total
  1. Drug

    Sovateltide

    go.drugbank.com/drugs/DB06138
    Investigational

    SPI-1620 is an endothelin B receptor agonist. In animal models SPI-1620 selectively and transiently increases tumor blood flow allowing increased delivery of anticancer agents to the tumor. It is being developed as an adjunct to chemothe...

  2. Drug

    Glesatinib

    go.drugbank.com/drugs/DB06302
    Investigational

  3. Drug

    Onalespib

    go.drugbank.com/drugs/DB06306
    Investigational

  4. Drug

    BNC105

    go.drugbank.com/drugs/DB06313
    Investigational

  5. Drug

    Tucidinostat

    go.drugbank.com/drugs/DB06334
    Investigational

  6. Drug

    Avasimibe

    go.drugbank.com/drugs/DB06442
    Experimental

  7. Drug

    E5531

    go.drugbank.com/drugs/DB06447
    Experimental

    E5531 is an endotoxin antagonist.

  8. Drug

    Levovirin

    go.drugbank.com/drugs/DB06523
    Experimental

  9. Drug

    N-chlorotaurine

    go.drugbank.com/drugs/DB06633
    Experimental

    N-chlorotaurine is an inhibitor of inducible nitric oxide synthase and IkappaB kinase.

  10. Drug

    AP5346

    go.drugbank.com/drugs/DB04992
    Investigational

    AP5346 is designed to target a diaminocyclohexane platinum (Pt) moiety to tumors through pH-sensitive linkage to a 25 kDa hydroxypropylmethacrylamide polymer. It is being pursued by Access Pharmaceuticals, Inc.